DCOY

Decoy Therapeutics Inc. NASDAQ Listed Jan 29, 2015

Healthcare ·Biotechnology ·US · decoytx.com

$7.31

-4.07% vs $7.62

Mkt Cap $3.5M

52w Low $4.41 1.7% of range 52w High $179.88

50d MA $6.26 200d MA $15.78

P/E (TTM) -0.2x

EV/EBITDA —

P/B 0.6x

Debt/Equity 0.0x

ROE -212.6%

P/FCF -0.7x

RSI (14) 57.80

ATR (14) $1.04

Beta 0.36

50d MA $6.26

200d MA $15.78

Avg Volume 457.7K

Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.

SIC Code

2834

CIK (SEC)

1615219

Phone

1 617-314-9333

One Broadway · Cambridge, MA 02142 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 3, 2026	AMC	-6.48	-6.48	+0.0%	—	—	—	—	—	—	—	—
Nov 14, 2025	AMC	-33.60	-1.81	+94.6%	14.40	-6.7%	-23.4%	-6.8%	-8.3%	-4.7%	+16.1%	—
Aug 12, 2025	AMC	-33.00	-6.75	+79.5%	99.00	-10.9%	-12.0%	-6.5%	+2.1%	-3.6%	-15.3%	—
May 14, 2025	AMC	-36.00	-15.44	+57.1%	156.60	+1.1%	-2.3%	-2.3%	-1.8%	-3.7%	-0.7%	—
Mar 21, 2025	AMC	-34.65	-9.90	+71.4%	171.60	-2.4%	+0.8%	-1.1%	-9.8%	+7.3%	-6.3%	—
Nov 14, 2024	AMC	-2.40	-11.39	-374.6%	248.40	+0.0%	-2.9%	+3.0%	+2.2%	-0.7%	+4.3%	—
Aug 9, 2024	AMC	-803.60	-35.53	+95.6%	414.00	+4.8%	-5.2%	-10.1%	+0.0%	+2.6%	-5.5%	—
May 13, 2024	AMC	-803.60	-49.18	+93.9%	705.60	-5.1%	-7.1%	+0.5%	+7.1%	+1.0%	+1.0%	—
Mar 22, 2024	AMC	-121.14	-26.39	+78.2%	892.80	+20.6%	-17.7%	-3.9%	-1.0%	+9.0%	-6.6%	—
Nov 9, 2023	AMC	-128.34	-77.96	+39.3%	1094.40	-1.3%	+1.3%	-6.5%	+2.8%	-0.2%	-6.6%	—
Aug 10, 2023	AMC	-151.12	-171.51	-13.5%	991.80	-2.7%	-6.0%	+0.0%	+10.2%	+5.1%	+17.2%	—
May 11, 2023	AMC	-237.48	-267.47	-12.6%	2016.00	+0.7%	-2.1%	+5.1%	-2.8%	+2.1%	-0.7%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 11	HC Wainwright & Co.	Maintains	Buy → Buy	—	$18000.00	$16632.00	-7.6%	-26.6%	+0.8%	-7.0%	+3.7%	+9.4%

Institutional (13F) — Top 1 All ↗

#	Manager	Shares	Value	Chg	Period
1	Ubs Group Ag	546	$4K	New	Mar 2026

Mutual Funds / ETFs (N-PORT) — Top 0 All ↗

No N-PORT holders found.

Data updated apr 25, 2026 4:48am · Source: financialmodelingprep.com